White Matter Abnormalities and Animal Models Examining a Putative Role of Altered White Matter in Schizophrenia

Abstract EN

Schizophrenia is a severe mental disorder affecting about 1% of the population worldwide.

Although the dopamine (DA) hypothesis is still keeping a dominant position in schizophrenia research, new advances have been emerging in recent years, which suggest the implication of white matter abnormalities in schizophrenia.

In this paper, we will briefly review some of recent human studies showing white matter abnormalities in schizophrenic brains and altered oligodendrocyte-(OL-) and myelin-related genes in patients with schizophrenia and will consider abnormal behaviors reported in patients with white matter diseases.

Following these, we will selectively introduce some animal models examining a putative role of white matter abnormalities in schizophrenia.

The emphasis will be put on the cuprizone (CPZ) model.

CPZ-fed mice show demyelination and OLs loss, display schizophrenia-related behaviors, and have higher DA levels in the prefrontal cortex.

These features suggest that the CPZ model is a novel animal model of schizophrenia.